Awakn Life Sciences has announced the signing of a five-year lease to open a larger Awakn Clinics Oslo.
The move to the new Oslo premises is the first stage of Awakn’s Nordic expansion plans.
Awakn Clinics Oslo’s new location will be a sic-treatment room clinic situated near the centre of Oslo and will replace the existing clinic. The new clinic will have increased capacity for treating clients and will also provide the potential to deliver research and clinical trials on-site.
The clinic is expected to finish the completion of renovations in early 2023 with the opening expected soon after that in Q2, and the next stage in Awakn’s Nordic expansion is expected to be a clinic opening in Trondheim next year.
Awakn’s CEO, Anthony Tennyson, commented: “We are very excited by this progress and feel it is the right time to begin our Nordic expansion plans.
“The reception to Awakn since our opening in in Norway has been excellent and with our new location, we will have the capacity to treat a significantly higher number of clients, who unfortunately are in desperate need of a new more effective treatment.
“As a company, providing that option and being able to help our clients at their lowest point, is what drives us every day.”
The clinic will be led by Awakn’s Regional Director of the Nordics, Dr Lowan Stewart a renowned figure in the Nordic medical community, who was responsible for the adoption of ketamine therapy into the public healthcare system in Norway.
